PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: MiMedx Group Inc (NASDAQ:MDXG), Phoenix New Media Ltd ADR (NYSE:FENG), Yamana Gold Inc. (USA) (NYSE:AUY), Idera Pharmaceuticals Inc (NASDAQ:IDRA)
MiMedx Group Inc (NASDAQ:MDXG) showed a volume of 5.53 million shares by the end of last trade whereas the average volume of the stock remained 490,567.00 shares. The stock opened the session at $7.25 but then moved to $7.93. At that price, the stock showed a positive performance of 13.77%. MiMedx Group, Inc. (MiMedx) is an integrated developer, manufacturer and marketer of regenerative biomaterial products processed from human amniotic membrane. The Company’s biomaterial platform technologies include the device technologies HydroFix and CollaFix, and tissue technologies, AmnioFix and EpiFix. Its tissue technologies are processed from human amniotic membrane that is derived from the donated placentas.
Will MDXG Continue To Move Higher? Find Out Here
Phoenix New Media Ltd ADR (NYSE:FENG) opened the session at $8.56 and closed the session at $8.99. The stock showed a positive performance of 4.66% in previous trading session. Phoenix New Media Limited (PNM) is a new media company providing content on an integrated platform across Internet, mobile and television (TV) channels in China. PNM enables consumers to access professional news and other content and share user-generated content (UGC), on the Internet and through their mobile devices. The Company also transmits its UGC and in-house produced content to TV viewers primarily through Phoenix TV.
For How Long FENG will fight for Profitability? Read This Trend Analysis report
Yamana Gold Inc. (USA) (NYSE:AUY) opened the session at $8.48 and closed the session at $8.66. Traded with volume of 5.39 million shares in the prior session and the average volume of the stock remained 6.72 million shares. The beta of the stock remained 0.36. Yamana Gold Inc. (Yamana) is a gold producer, engaged in gold production, gold development stage properties, exploration properties and land positions in Brazil, Chile, Argentina, Mexico and Colombia. The Company’s producing mines include Chapada Mine (Brazil), El Penon Mine (Chile), Jacobina Mining Complex (Brazil),
Is AUY a Solid Investment at These Levels? Read This Report For Details
Idera Pharmaceuticals Inc (NASDAQ:IDRA) the stock advanced 19.78% and finished the session at $3.27. Traded with volume of 5.36 million shares in the prior session and the average volume of the stock remained 1.05 million shares. The beta of the stock remained 1.94. Idera Pharmaceuticals, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of novel synthetic deoxyribonucleic acid (DNA) - and ribonucleic acid (RNA) - based drug candidates. The Company is developing drug candidates that are designed to modulate immune responses mediated through Toll-like Receptors (TLRs). It is also evaluating gene silencing oligonucleotides (GSOs), which inhibit the production of disease-associated proteins by targeting RNA.
Will IDRA Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)